MedPath

nderstanding the nature of day/night clock gene Abnormalities in Cardiovascular Diseases and their effect on potency of Cardiac Medicines

Not Applicable
Conditions
Health Condition 1: I219- Acute myocardial infarction, unspecified
Registration Number
CTRI/2023/08/057003
Lead Sponsor
IIT hyderabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Adults of either gender ( <40 years young group, >40 years older group) suffering from

cardiovascular diseases (a narrow age range to avoid age-related circadian variations)

2. Cardiovascular disease diagnosed based on the clinical manifestations and confirmed

through an electrocardiogram (ECG)

3. Age and gender (and occupation, if possible) matched healthy participants as control

subjects based on medical history, clinical examination, and laboratory investigations

4. Subjects (patients and controls) willing to provide written informed consent and comply

with protocol requirements

Exclusion Criteria

1. Subjects reluctant to provide written informed consent or to comply with the study

protocol

2. Subjects with any significant medical history (ongoing or in the recent past)

3. Currently diagnosed with a neurological or sleep disorder (narcolepsy, obstructive sleep

apnea, restless leg syndrome) and/or being prescribed a non-psychotropic medication that

can alter sleep and circadian rhythms (such as cortisone)

4. Subjects with severe anemia (Hb level < 7g/dL)

5. Female patients who are pregnant at the time of enrolment

6. Subjects who are chronic alcoholics or smokers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath